576 related articles for article (PubMed ID: 16960091)
1. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study.
Jauch EC; Lindsell C; Broderick J; Fagan SC; Tilley BC; Levine SR;
Stroke; 2006 Oct; 37(10):2508-13. PubMed ID: 16960091
[TBL] [Abstract][Full Text] [Related]
2. Correlation of levels of neuronal and glial markers with radiological measures of infarct volume in ischaemic stroke: a systematic review.
Ahmad O; Wardlaw J; Whiteley WN
Cerebrovasc Dis; 2012; 33(1):47-54. PubMed ID: 22133844
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
[TBL] [Abstract][Full Text] [Related]
4. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients.
Baker AJ; Rhind SG; Morrison LJ; Black S; Crnko NT; Shek PN; Rizoli SB
J Neurotrauma; 2009 Aug; 26(8):1227-40. PubMed ID: 19637968
[TBL] [Abstract][Full Text] [Related]
5. AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels.
Elting JW; Sulter GA; Kaste M; Lees KR; Diener HC; Hommel M; Versavel M; Teelken AW; De Keyser J
Stroke; 2002 Dec; 33(12):2813-8. PubMed ID: 12468775
[TBL] [Abstract][Full Text] [Related]
6. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity.
Vos PE; van Gils M; Beems T; Zimmerman C; Verbeek MM
Eur J Neurol; 2006 Jun; 13(6):632-8. PubMed ID: 16796588
[TBL] [Abstract][Full Text] [Related]
7. Serum neuron specific enolase level as a predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis.
Lu K; Xu X; Cui S; Wang F; Zhang B; Zhao Y
J Neurol Sci; 2015 Dec; 359(1-2):202-6. PubMed ID: 26671113
[TBL] [Abstract][Full Text] [Related]
8. Serum biomarker concentrations and outcome after pediatric traumatic brain injury.
Berger RP; Beers SR; Richichi R; Wiesman D; Adelson PD
J Neurotrauma; 2007 Dec; 24(12):1793-801. PubMed ID: 18159990
[TBL] [Abstract][Full Text] [Related]
9. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.
Brouns R; De Vil B; Cras P; De Surgeloose D; Mariën P; De Deyn PP
Clin Chem; 2010 Mar; 56(3):451-8. PubMed ID: 19959621
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children.
Beers SR; Berger RP; Adelson PD
J Neurotrauma; 2007 Jan; 24(1):97-105. PubMed ID: 17263673
[TBL] [Abstract][Full Text] [Related]
11. [Changes of protein S100B serum concentration during ischemic and hemorrhagic stroke in relation to the volume of stroke lesion].
Weglewski A; Ryglewicz D; Mular A; Juryńczyk J
Neurol Neurochir Pol; 2005; 39(4):310-7. PubMed ID: 16096936
[TBL] [Abstract][Full Text] [Related]
12. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
Stroke; 2000 Dec; 31(12):2912-9. PubMed ID: 11108748
[TBL] [Abstract][Full Text] [Related]
13. Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke.
Brea D; Sobrino T; Blanco M; Cristobo I; Rodríguez-González R; Rodríguez-Yañez M; Moldes O; Agulla J; Leira R; Castillo J
Clin Chem Lab Med; 2009; 47(12):1513-8. PubMed ID: 19863297
[TBL] [Abstract][Full Text] [Related]
14. Are serum S100beta proteins and neuron-specific enolase predictors of cerebral damage in cardiovascular surgery?
Ishida K; Gohara T; Kawata R; Ohtake K; Morimoto Y; Sakabe T
J Cardiothorac Vasc Anesth; 2003 Feb; 17(1):4-9. PubMed ID: 12635053
[TBL] [Abstract][Full Text] [Related]
15. Initial body temperature in ischemic stroke: nonpotentiation of tissue-type plasminogen activator benefit and inverse association with severity.
Kim SH; Saver JL
Stroke; 2015 Jan; 46(1):132-6. PubMed ID: 25424482
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of selected biochemical markers of brain damage for functional outcome in ischaemic stroke patients.
Sienkiewicz-Jarosz H; Gałecka-Wolska M; Bidziński A; Turzyńska D; Sobolewska A; Lipska B; Płaźnik A; Ryglewicz D
Neurol Neurochir Pol; 2009; 43(2):126-33. PubMed ID: 19484689
[TBL] [Abstract][Full Text] [Related]
17. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke.
Heiss WD; Grond M; Thiel A; von Stockhausen HM; Rudolf J; Ghaemi M; Löttgen J; Stenzel C; Pawlik G
J Cereb Blood Flow Metab; 1998 Dec; 18(12):1298-307. PubMed ID: 9850142
[TBL] [Abstract][Full Text] [Related]
18. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
[TBL] [Abstract][Full Text] [Related]
19. Modeling serum level of s100β and bispectral index to predict outcome after cardiac arrest.
Stammet P; Wagner DR; Gilson G; Devaux Y
J Am Coll Cardiol; 2013 Aug; 62(9):851-8. PubMed ID: 23684684
[TBL] [Abstract][Full Text] [Related]
20. Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes.
Picanço MR; Christensen S; Campbell BC; Churilov L; Parsons MW; Desmond PM; Barber PA; Levi CR; Bladin CF; Donnan GA; Davis SM;
Int J Stroke; 2014 Apr; 9(3):266-9. PubMed ID: 24256139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
